Amiral Gestion Invests $1.68 Million in Colgate-Palmolive Company $CL

Amiral Gestion bought a new stake in Colgate-Palmolive Company (NYSE:CL) during the 3rd quarter, Holdings Channel reports. The firm bought 21,000 shares of the company’s stock, valued at approximately $1,679,000. Colgate-Palmolive accounts for about 0.6% of Amiral Gestion’s investment portfolio, making the stock its 21st largest holding.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Westside Investment Management Inc. increased its position in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the period. Saudi Central Bank bought a new stake in Colgate-Palmolive during the first quarter worth $29,000. Vermillion & White Wealth Management Group LLC boosted its holdings in shares of Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares in the last quarter. Ransom Advisory Ltd bought a new position in shares of Colgate-Palmolive in the 1st quarter valued at $33,000. Finally, MTM Investment Management LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth $39,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 2.5%

Shares of NYSE:CL opened at $77.73 on Friday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. The business’s 50-day moving average is $78.31 and its 200-day moving average is $83.22. The company has a market capitalization of $62.66 billion, a price-to-earnings ratio of 21.77, a P/E/G ratio of 5.68 and a beta of 0.30.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.91 earnings per share. Equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CL. Bank of America decreased their target price on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a research note on Monday, November 3rd. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research report on Tuesday, December 9th. UBS Group decreased their price target on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Finally, JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $87.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $88.81.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.